Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Role of ctDNA in MRD

Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of next-generation sequencing and circulating tumor DNA (ctDNA) in the treatment and management of breast cancer, such as disease monitoring and minimal residual disease (MRD). This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.